BRIEF published on 10/28/2025 at 07:35, 1 month 7 days ago Symrise AG Q3 2025 Sales Overview Organic Growth Global Demand Bond Issue ONE Symrise Strategy Symrise Q3 2025
PRESS RELEASE published on 10/28/2025 at 07:30, 1 month 7 days ago Symrise Reports Third Quarter 2025 Sales Symrise AG reports 1.4% organic sales growth in Q3 2025, updated guidance for 2025, and successful €800 million bond placement Financial Results Organic Growth Symrise AG Bond Placement Q3 2025
BRIEF published on 09/17/2025 at 08:05, 2 months 17 days ago Symrise Secures €800 Million Bond Amid Strong Demand Investor Confidence Financial Strategy Symrise €800 Million Bond European Debt Market
PRESS RELEASE published on 09/17/2025 at 08:00, 2 months 17 days ago Symrise announces successful placement of €800 million bond Symrise AG successfully completes placement of €800 million bond on European debt capital market with a 7-year term and 3.25% coupon rate, receiving high demand from investors Investors Coupon Rate Symrise AG €800 Million Bond Debt Capital Market
BRIEF published on 09/12/2025 at 11:43, 2 months 22 days ago Symrise Secures Investment Grade Ratings from S&P Global and Moody's Moody's Symrise AG Credit Ratings Investment Grade S&P Global
PRESS RELEASE published on 09/12/2025 at 11:38, 2 months 22 days ago Symrise Receives Inaugural Investment Grade Credit Ratings from S&P Global and Moody’s Symrise AG receives inaugural investment grade credit ratings from S&P Global and Moody's, reflecting financial strength and robust business strategy Moody's Symrise AG Credit Ratings Investment Grade S&P Global
BRIEF published on 07/30/2025 at 07:40, 4 months 5 days ago Michael Friede Joins Symrise as Executive Board Member and President of Scent & Care Executive Board Symrise AG Fragrance Industry Scent & Care Michael Friede
BRIEF published on 07/30/2025 at 07:35, 4 months 5 days ago Symrise Posts First Half 2025 Results with Steady Growth EBITDA Margin Organic Growth 2025 Results Symrise ONE SYM Strategy
PRESS RELEASE published on 07/30/2025 at 07:35, 4 months 5 days ago Michael Friede has been appointed Symrise Executive Board Member and President Scent & Care Symrise AG appoints Michael Friede as Executive Board Member and President Scent & Care segment, bringing extensive international management experience and industry-specific knowledge President Symrise AG Executive Board Member Scent & Care Michael Friede
PRESS RELEASE published on 07/30/2025 at 07:30, 4 months 5 days ago Symrise Reports First Half 2025 Results Symrise AG reports organic growth and increased EBITDA margin in H1 2025 results, appoints new Executive Board Member, and updates guidance amidst global demand shifts EBITDA Margin Organic Growth Global Demand Symrise AG H1 2025 Results
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
